| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/18/2011 | EP2321340A1 Novel melanoma antigen peptide and uses thereof |
| 05/18/2011 | EP2320947A2 Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and intiviral, antibacterial, and anticancer agents |
| 05/18/2011 | EP2320946A1 Allergoids derived from allergenes |
| 05/18/2011 | EP2320945A2 Stable anthrax vaccine formulations |
| 05/18/2011 | EP2320944A1 Vaccines comprising tb10.4 |
| 05/18/2011 | EP2320943A1 Cattle vaccines |
| 05/18/2011 | EP2320942A2 Diagnostic antibody assay |
| 05/18/2011 | EP2320941A2 Composition and methods for eliciting an immune response |
| 05/18/2011 | EP2320932A2 Methods of predicting cancer lethality using replikin counts |
| 05/18/2011 | EP2164516B9 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins |
| 05/18/2011 | EP2089433B1 Therapy targeting cathepsin s |
| 05/18/2011 | EP2041181B1 Specific protease inhibitors and their use in cancer therapy |
| 05/18/2011 | EP1966245B1 Anti-cd19 antibodies with reduced immunogenicity |
| 05/18/2011 | EP1910420B1 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 05/18/2011 | EP1732950B1 Antibodies to erythropoietin receptor and uses thereof |
| 05/18/2011 | EP1662007B1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 05/18/2011 | EP1478764B1 Humanized collagen antibodies and related methods |
| 05/18/2011 | EP1356298B1 Diagnosis of disease |
| 05/18/2011 | EP1032595B1 Nucleic acids involved in the responder phenotype and applications thereof |
| 05/18/2011 | CN1961002B Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/18/2011 | CN1810970B CpG-containing single-stranded deoxynucleotide, its vaccine composition and their application |
| 05/18/2011 | CN1377415B 疫苗组合物 Vaccine compositions |
| 05/18/2011 | CN102066420A 1d05 pcsk9 antagonists |
| 05/18/2011 | CN102066418A Anti-HIV monoclonal antibody |
| 05/18/2011 | CN102066411A Leishmania vaccine using sand fly salivary immunogen |
| 05/18/2011 | CN102066394A Analogues of glycolipids useful as immunoadjuvants |
| 05/18/2011 | CN102065895A Therapeutic combinations of anti-IGF-1R antibodies and other compounds |
| 05/18/2011 | CN102065894A An antibody bound synthetic vesicle containing active agent molecules |
| 05/18/2011 | CN102065893A Delivery of LFA-1 antagonists to the gastrointestinal system |
| 05/18/2011 | CN102065892A Compositions and methods for crystallizing antibody fragments |
| 05/18/2011 | CN102065891A Novel synergistic effects |
| 05/18/2011 | CN102065890A Chimeric porcine circovirus PCV2Gen-1Rep and uses thereof |
| 05/18/2011 | CN102065889A Vaccine |
| 05/18/2011 | CN102065888A Anti-VEGF antibody |
| 05/18/2011 | CN102065881A Stable amyloid BETA monomers and oligomers |
| 05/18/2011 | CN102065880A Immunotherapies employing self-assembling vaccines |
| 05/18/2011 | CN102061288A Molecular antigen arrays using a virus like particle derived from the AP205 coat protein |
| 05/18/2011 | CN102060925A Interleukin-13 antibody composition |
| 05/18/2011 | CN102060915A Modifiable loca of human type 3 adenovirus hexon and application thereof |
| 05/18/2011 | CN102060911A Polypeptide combined with various amyloid protein monomers simultaneously and application thereof |
| 05/18/2011 | CN102058884A Grass carp injection vaccine synergist and preparation method thereof |
| 05/18/2011 | CN102058883A Application of thymopentin in a water-soluble injection vaccines and a freeze-dried injection vaccines |
| 05/18/2011 | CN102058882A Method of preparing hepatitis A inactivated vaccine |
| 05/18/2011 | CN102058881A Gene recombinant vaccine for preventing enterovirus 71 infection and preparation method thereof |
| 05/18/2011 | CN102058880A Method for producing trivalent inactivated vaccines for porcine infectious pleuropneumonia |
| 05/18/2011 | CN102058879A Oral cancer nano vaccine and structuring method thereof |
| 05/18/2011 | CN101463088B Anti-soman antibody |
| 05/18/2011 | CN101463087B Anti-ricin antibody |
| 05/18/2011 | CN101362794B B cell epitope of follicle-stimulating hormone receptor and antigen peptides containing thereof |
| 05/18/2011 | CN101347616B Composing prescription of novel safe JY immunoadjuvant system and uses thereof |
| 05/18/2011 | CN101209351B Ankara vaccinia virus genetic engineering vaccine for pig replication and respiration complex |
| 05/18/2011 | CN101112619B 疫苗组合物 Vaccine compositions |
| 05/18/2011 | CN101072875B Novel cancer antigen peptide and the use thereof |
| 05/17/2011 | USRE42373 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 05/17/2011 | US7943745 Anti-CD98 antibody |
| 05/17/2011 | US7943744 ICAM-1 binding antibodies |
| 05/17/2011 | US7943742 Anti-αvβ6 antibodies and uses thereof |
| 05/17/2011 | US7943588 Method for preventing or treating neuropathic pain |
| 05/17/2011 | US7943587 Administering to the individual, one or more nucleic acid molecules that comprise a nucleotide sequence that encodes an immunogen and a nucleotide sequence that encodes an Major Histocompatibility Complex antigen |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | US7943375 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 05/17/2011 | US7943343 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/17/2011 | US7943332 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 05/17/2011 | US7943316 Immunostimulatory oligonucleotides and uses thereof |
| 05/17/2011 | US7943154 Method for producing multiple emulsions that are stable in storage |
| 05/17/2011 | US7943153 Vaccines for Mycoplasma bovis and methods of use |
| 05/17/2011 | US7943152 By injection into the eyelid or conjunctiva to reduce secretions from the meibomian glands; nonsurgical; antisecretory agents |
| 05/17/2011 | US7943151 Immunizing compositions and methods of use |
| 05/17/2011 | US7943150 Immunizing compositions and methods of use |
| 05/17/2011 | US7943149 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 05/17/2011 | US7943148 Amino acid sites in Flavivirus E proteins useful for development of diagnostics and vaccines |
| 05/17/2011 | US7943147 dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants |
| 05/17/2011 | US7943146 Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface |
| 05/17/2011 | US7943144 Herpes simplex virus complex |
| 05/17/2011 | US7943143 Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof |
| 05/17/2011 | US7943141 Activated polyoxazolines and compositions comprising the same |
| 05/17/2011 | US7943140 Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of HIV-1 |
| 05/17/2011 | US7943139 Methods of generating a humoral immune response against human immunodeficiency virus (HIV) comprising administering Nef apoptotic motif-containing polypeptide-conjugates |
| 05/17/2011 | US7943138 Survivin peptides as cancer vaccines |
| 05/17/2011 | US7943137 FPRL1 ligands and use thereof |
| 05/17/2011 | US7943136 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 05/17/2011 | US7943135 Method of treatment using anti-factor D antibodies |
| 05/17/2011 | US7943134 Compositions and methods for identifying response targets and treating flavivirus infection responses |
| 05/17/2011 | US7943133 Mesothelin antibody protein fusions and methods of use |
| 05/17/2011 | US7943132 Methods of treating pain using antagonists of IL-31, IL-31RA and/or OSMRB |
| 05/17/2011 | US7943131 Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists |
| 05/17/2011 | US7943130 Methods and compositions relating to CCR5 antagonist, IFN-γ and IL-13 induced inflammation |
| 05/17/2011 | US7943129 Single-domain brain-targeting antibody fragments derived from llama antibodies |
| 05/17/2011 | US7943125 Attenuated gram negative bacteria |
| 05/17/2011 | US7943124 Composition for immunostimulation |
| 05/17/2011 | US7943122 Attenuated bacteria useful in vaccines |
| 05/17/2011 | US7943121 comprising heavy chain and light chain variable regions, that binds to human interleukin-1 beta with a dissociation constant less than 1 pM; time-release and sustained-release drugs |
| 05/17/2011 | US7942846 Needleless syringe using supersonic gas flow for particle delivery |
| 05/17/2011 | CA2558313C New expression tools for multiprotein applications |
| 05/17/2011 | CA2502785C Neisserial mutant strain lacking expression of a glycosyltransferase |
| 05/17/2011 | CA2462710C Polypeptide antigen forming a mimetic structure of the gp41 intermediate state |
| 05/17/2011 | CA2451521C Use of poly-glu, tyr for neuroprotective therapy |
| 05/17/2011 | CA2397194C Alpha v integrin receptor antagonists |
| 05/17/2011 | CA2333582C Nicotine immunogen |
| 05/17/2011 | CA2308007C Enhancer for antibody to lymphocytic tumors |